MAPT and Alzheimer disease: COG112, an apolipoprotein E mimetic, inhibits the interaction between SET and PP2A with resulting increased PP2A activity and reduction in phosphorylation of tau in the hippocampus and cerebral cortex of AD mouse models [135].